Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 02 - 23 source : Www.biospace.com save search
U.S. FDA Licenses Certara’s Immunogenicity SimulatorAffirms the advancements of innovative biosimulation technology and its growing impact in R&D
Published: 2022-02-23 (Crawled : 23:00) - biospace.com/
CERT | $16.19 -4.48% -4.69% 490K
|
|
| O: 0.86%
H: 2.01%
C: -7.21%
fda license technology growing
BD Appoints Shana Neal as Chief People Officer
Published: 2022-02-23 (Crawled : 23:00) - biospace.com/
BDX | $233.15 0.41% -0.86% 650K
|
Health Technology
|
| O: 0.22%
H: 1.9%
C: 1.48%
Fulgent Genetics Announces Strategic Investment in Spatial Genomics
Published: 2022-02-23 (Crawled : 23:00) - biospace.com/
FLGT | $20.12 0.15% 0.15% 220K
|
Health Services
|
| O: 1.81%
H: 0.95%
C: -5.14%
genetic genomics ces genomic
ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference
Published: 2022-02-23 (Crawled : 23:00) - biospace.com/
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 1.0%
H: 3.16%
C: -5.52%
health conference
Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
Published: 2022-02-23 (Crawled : 23:00) - biospace.com/
QTRX | $15.79 0.25% 0.32% 360K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -3.53%
financial results corporation results
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Published: 2022-02-23 (Crawled : 22:00) - biospace.com/
RCUS 4 | $14.84 0.0% 910K
|
Health Technology
|
| O: 1.47%
H: 1.53%
C: -0.96%
financial results arcus report bioscience results
US Patent Office Grants Patent for COVID-19 Risk Test
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
GENE | News 0 d | $2.36 -25.32% -33.9% 88K
|
Health Technology
|
| O: -2.62%
H: 4.51%
C: 2.69%
covid-19 risk patent covid test grant granted
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Therapies
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
NTLA | $21.32 -0.84% -0.94% 900K
|
Health Technology
|
| O: 1.57%
H: 1.39%
C: -6.39%
therapeutics crispr intel therapy
PacBio Welcomes Dr. Michael Eberle as Vice President of Computational BiologyGenomics Industry Veteran to Oversee Development of Robust Computational Biology Program
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PACB | $1.46 4.29% 4.76% 18M
|
Health Technology
|
| O: 3.78%
H: 1.12%
C: -6.26%
genomics genomic program computational
Amylyx Pharmaceuticals Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
AMLX | $1.98 -1.0% -1.52% 860K
|
|
| O: -3.54%
H: 5.46%
C: 0.1%
als
Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.0 -1.96% -1.75% 520K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: -3.95%
day technology therapeutics test set
4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
LBPS | $1.65 -0.61%
|
Manufacturing
|
| O: 4.27%
H: 0.0%
C: -5.92%
genomics genomic pharma
aTyr Pharma to Participate in Panel at National Institutes of Health Rare Disease Day®Panel to take place on Monday, February 28, 2022, at 2:55pm EST / 11:55am PST
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
LIFE | $1.625 2.2% 2.15% 260K
|
Health Technology
|
| O: 1.37%
H: 0.19%
C: -2.71%
day health rare disease
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
CO | $2.9876 -2.1%
|
Health Services
|
| O: 0.24%
H: 1.18%
C: -1.18%
blood financial results corporation report results
Pieris Pharmaceuticals To Host Full-Year 2021 Investor Call and Provide Corporate Update on March 1, 2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PIRS | $0.1552 -1.21% -0.06% 620K
|
Health Technology
|
| O: 1.32%
H: 5.21%
C: -1.95%
als
Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
RANI | $6.11 -22.17% -28.48% 580K
|
|
| O: 3.45%
H: 8.59%
C: -11.52%
financial results device liver therapeutics report results
Clovis Oncology Announces 2021 Operating Results and Anticipated 2022 Development Milestones
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 1.18%
H: 0.88%
C: -5.26%
one milestone
Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
ALIM | $3.4 -4.23% -4.41% 57K
|
Health Technology
|
| O: -2.37%
H: 5.43%
C: 2.86%
iluvien
Horizon Therapeutics plc Initiates Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating Teprotumumab for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.97%
H: 0.38%
C: -2.35%
treatment eye eye disease trial therapeutics disease active phase 3
Ayala Pharmaceuticals Announces Completion of Enrollment in Part A of RINGSIDE, a Pivotal Phase 2/3 Study of AL102 in Desmoid TumorsInterim Results expected mid-2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: -4.52%
H: 7.35%
C: -4.98%
al102 phase 2 als phase 2/3 enroll
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.